Abstract:Objective:To investigate the effectiveness of surgical treatment for patients with T 4 stage prostate cancer. Methods:The clinical data and prognosis of 18 patients with T 4 stage prostate cancer treated in Shanghai Tenth People's Hospital from July 2013 to December 2019 were retrospectively analyzed. The average age of these 18 patients was 68.3 (53-81)years. 10 patients were castration resistant prostate cancer (CRPC) and 8 patients were hormone-sensitive prostate cancer (HSPC). 10 CRPC patients were treated with surgical treatment due to bladder clot packing and/or lower urinary tract obstruction. 8 HSPC patients had severe hematuria, severe dysuria and local symptoms. The KPS scores of all patients were ≥80 points with an average score of 84 (80-90). The average QOL score of 18 patients was 28 (21-32). 2 cases in 18 patients underwent total pelvic resection for rectal invasion (one CRPC and one HSPC). 7 cases underwent radical cystoprostatectomy for ureteral invasion (5 cases of CRPC, 2 cases of HSPC), 9 cases underwent bladder preservation surgery for bladder neck invasion (4 cases of CRPC, 5 cases of HSPC), of which 4 cases of enlarged lymph node dissection were all HSPC patients. Results:All cases of T 4 stage prostate cancer patients operation were successfully completed, the average operation time was 256 (219-310)min and the median intraoperative blood loss was about 300 (250-350)ml. Four of them (3 cases of CRPC and 1 case of HSPC) received blood transfusion after operation. The average postoperative hospital stay was 21(11-37) days. All 18 cases were followed up and the median follow-up time was 23.8 months. There was no perioperative death, and no bladder-preserving patients had true urinary incontinence or bladder outlet stenosis.2 CRPC cases died 8 and 15 months after surgery respectively, 7 patients were PSA relapse treated with docetaxel or abiterone therapy, and 1 HSPC patient with rectal invasion was followed up for 58 months after total pelvic resection, the PSA level was still 0.003ng/ml, no distant metastasis was found. 8 cases of hormone-sensitive patients were treated with endocrine therapy, and PSA was less than 0.2 ng/ml. The average QOL of 18 patients 3 months after operation was 37 points (25-45), which was significantly higher than that before operation. The average maximum urine flow rate of patients with bladder preservation was 23(19-25)ml/s. Conclusions:For T 4 stage prostate cancer, surgical treatment is feasible and safe for doctors with extensive surgical experience. For CRPC patients, the surgery can significantly improve short-term symptoms and quality of life, and long-term benefits need to be further evaluated with a large sample. For HSPC patients, it can not only improve clinical symptoms and QOL of patients, but also provide long-term benefits.

Diagnosis and treatment of advanced prostatic cancer(report of 84 cases)

Combined therapy in the management of advanced prostatic cancer

High-risk benign prostatic hyperplasia patients treated with transurethral resection of prostate

Clinical Analysis of Prostate Cancer with Bone Metastasis: A Report of 63 Cases

Experience in treating advanced prostate cancer with bladder outlet obstruction]

The clinical analysis on endocrine therapy of late prostate carcinoma

Transurethral plasmakinetic prostatectomy combined with hormone therapy for lower urinary tract obstruction caused by advanced prostate cancer

Clinical Analysis on the Treatment of Prostate Cancer

Clinical Observation of Plasma Kinetic Resection of Prostate Combined with Endocrine Therapy in the Treatment of Advanced Prostate Cancer with Bladder Outlet Obstruction

Comprehensive diagnosis and treatment of long-term survival metastatic prostate cancer: a case report and literature review

Clinical Analysis of Advanced Prostate Cancer Treated by Surgery in 25 Patients

Transurethral prostate resection for advanced prostate cancer in patients with bladder outlet obstruction

The experience of surgical treatment in T 4 stage prostate cancer

Long-term Outcome of Transurethral Resection of Prostate in Patients with Advanced Prostate Cancer and Bladder Outlet Obstruction

Transurethral Resection of the the Prostate for Lower Urinary Tract Obstruction from Advanced Prostate Cancer

Prostatic foamy gland carcinoma：diagnosis and treatment

Comprehensive treatment of metastatic hormone sensitive prostate cancer: a case report and literature review

Bicalutamide in the Treatment of Advanced Prostate Cancer:A 52 Case Report

Effect Observation of TURP Combined with Androgen Blockade for Advanced Prostate Cancer with Bladder Outlet Obstruction

Local Advanced Prostate Cancer Treated by Combination of ~(125)I Brachytherapy and Surgical Castrati(Report of 40 Cases)

A retrospection of 1345 cases of inpatients with Benign prostatic hyperplasia in the past 10 years